Alexander Schmitz
Alexander Schmitz is an Investment Director at Endeavour Vision, a Geneva-based venture fund investing in growth-stage medical device and digital health companies in the U.S. and Europe. Alexander Schmitz has nearly two decades of business and strategy experience in both medical device and high-technology companies. From 2005 to 2014, he helped Biosensors International Group develop its interventional cardiology business, from less than $5 million in annual revenues to more than $300 million, most recently serving as Vice President or Business Development.
Prior to Biosensors, he worked at LogiSpring, the corporate venture fund of the TNT Post Group, and at MicroStrategy, a leading provider of business intelligence software. Alexander Schmitz began his career as a consultant at McKinsey & Company, where, in addition to serving clients, he spent a year with the McKinsey Global Institute. He earned his MBA from INSEAD and a BSFS in economics, magna cum laude, from Georgetown University’s School of Foreign Service.
Latest contributions
Coronary interventions: first-in-man and novel devices
20 May 2026 – From EuroPCR 2026
Explore pioneering advancements in coronary interventions with first-in-man and novel devices. This session presents groundbreaking studies including cryotherapy for vulnerable plaques, a novel intravascular crossing system for coronary CTOs, sirolimus-coated retrievable scaffold therapy for in-stent restenosis, real-time intravascular photoacoustic imaging of lipid-rich plaques, and the inaugural...
The Jon DeHaan Foundation Award competition
18 May 2026 – From EuroPCR 2026
Explore the forefront of interventional cardiology innovation with the Jon DeHaan Foundation Award competition, featuring pioneering solutions for valvular heart disease and mechanical support. This session highlights novel devices such as TriFlo for tricuspid regurgitation, the extravascular ventricular assist device (eVAD System), and the first-in-human experience...
How will "Big Data" and artificial intelligence change the practice in Interventional Cardiology?
15 May 2023 – From PCR Innovators Day 2023
PCR Innovators Day - Competition for the Jon DeHaan Award
19 May 2022 – From EuroPCR 2022
Best-graded contributions for the Innovators Day were considered for this competition. Among them, find out more about transcatheter calcium modifying treatment of the stenotic aortic valve, capture technology for treating mitral regurgitation, or transcatheter microwave renal denervation guided by aorticorenal ganglion pacing.
PCR Innovators Day - Jon DeHaan Award winner announcement
19 May 2022 – From EuroPCR 2022
After a look back at the winners of previous editions, find out who the finalists are for 2022 before the suspense is lifted and the winners are finally revealed.
PCR Innovators Day Steering commitee
09 Jan 2017
Join the major actors in the field of innovation in interventional cardiology! Find out about the Steering Committee